The legacy success of sildenafil has undeniably transformed the healthcare landscape. However, investing in companies heavily focused on biosimilars and the declining patent protection surrounding this https://dirstop.com/story28259993/sildenafil-and-pharmaceutical-companies-a-risky-investment